Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children

Anne B. Chang; Richard S. Irwin; Hannah E. O’Farrell; Peter V. Dicpinigaitis; Suhani Goel; Ahmad Kantar; Julie M. Marchant

doi:10.3390/jcm12154879

Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children

Anne B. Chang, Richard S. Irwin, Hannah E. O’Farrell, Peter V. Dicpinigaitis, Suhani Goel, Ahmad Kantar, Julie M. Marchant

Child and Maternal Health

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

75 Downloads (Pure)

Abstract

In children and adults, chronic cough is a common symptom presenting to health professionals worldwide. It is internationally accepted that children with chronic cough should be managed with pediatric specific management guidelines. The newly proposed clinical entity of ‘cough hypersensitivity syndrome’ has gained significant attention in adult literature. Given the significant differences between childhood and adult chronic cough, including in respiratory physiology and anatomy, and cough sensitivity, we address the suitability of the use of cough hypersensitivity syndrome in children. We explore these differences between childhood and adult chronic cough, explain what cough hypersensitivity is and highlight why the term cough hypersensitivity syndrome should not be used in children.

Original language	English
Article number	4879
Pages (from-to)	1-12
Number of pages	12
Journal	Journal of Clinical Medicine
Volume	12
Issue number	15
DOIs	https://doi.org/10.3390/jcm12154879
Publication status	Published - Aug 2023

Bibliographical note

Funding Information:
H.E.O., S.G. and A.K. declare no conflict of interest. R.S.I. discloses that he is the Chair of the CHEST Expert Cough Panel and Co-developer of the Punum Cough Severity and Cough Quality of Life (CQLQ) patient-reported outcome measures. A.B.C. reports multiple grants from NHMRC and other fees to the institution from work relating to IDMC membership of an unlicensed vaccine (GSK), unlicensed monoclonal antibody for RSV (AZ) and a COVID-19 vaccine (Moderna), and advisor for study design (Zambon and Boehringer) outside the submitted work. P.V.D. reports remuneration for consultancy from Bayer AG, Bellus Health, Chiesi, Merck, and Shionogi.

Publisher Copyright:
© 2023 by the authors.

Access to Document

10.3390/jcm12154879

84336105-oaFinal published version, 264 KBLicence: CC BY

Cite this

@article{a5d535b688c34e878432fa596fa70135,

title = "Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children",

abstract = "In children and adults, chronic cough is a common symptom presenting to health professionals worldwide. It is internationally accepted that children with chronic cough should be managed with pediatric specific management guidelines. The newly proposed clinical entity of {\textquoteleft}cough hypersensitivity syndrome{\textquoteright} has gained significant attention in adult literature. Given the significant differences between childhood and adult chronic cough, including in respiratory physiology and anatomy, and cough sensitivity, we address the suitability of the use of cough hypersensitivity syndrome in children. We explore these differences between childhood and adult chronic cough, explain what cough hypersensitivity is and highlight why the term cough hypersensitivity syndrome should not be used in children.",

keywords = "children, cough, evidence, hypersensitivity, review",

author = "Chang, {Anne B.} and Irwin, {Richard S.} and O{\textquoteright}Farrell, {Hannah E.} and Dicpinigaitis, {Peter V.} and Suhani Goel and Ahmad Kantar and Marchant, {Julie M.}",

note = "Funding Information: H.E.O., S.G. and A.K. declare no conflict of interest. R.S.I. discloses that he is the Chair of the CHEST Expert Cough Panel and Co-developer of the Punum Cough Severity and Cough Quality of Life (CQLQ) patient-reported outcome measures. A.B.C. reports multiple grants from NHMRC and other fees to the institution from work relating to IDMC membership of an unlicensed vaccine (GSK), unlicensed monoclonal antibody for RSV (AZ) and a COVID-19 vaccine (Moderna), and advisor for study design (Zambon and Boehringer) outside the submitted work. P.V.D. reports remuneration for consultancy from Bayer AG, Bellus Health, Chiesi, Merck, and Shionogi. Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = aug,

doi = "10.3390/jcm12154879",

language = "English",

volume = "12",

pages = "1--12",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "15",

}

TY - JOUR

T1 - Cough Hypersensitivity Syndrome

T2 - Why Its Use Is Inappropriate in Children

AU - Chang, Anne B.

AU - Irwin, Richard S.

AU - O’Farrell, Hannah E.

AU - Dicpinigaitis, Peter V.

AU - Goel, Suhani

AU - Kantar, Ahmad

AU - Marchant, Julie M.

N1 - Funding Information: H.E.O., S.G. and A.K. declare no conflict of interest. R.S.I. discloses that he is the Chair of the CHEST Expert Cough Panel and Co-developer of the Punum Cough Severity and Cough Quality of Life (CQLQ) patient-reported outcome measures. A.B.C. reports multiple grants from NHMRC and other fees to the institution from work relating to IDMC membership of an unlicensed vaccine (GSK), unlicensed monoclonal antibody for RSV (AZ) and a COVID-19 vaccine (Moderna), and advisor for study design (Zambon and Boehringer) outside the submitted work. P.V.D. reports remuneration for consultancy from Bayer AG, Bellus Health, Chiesi, Merck, and Shionogi. Publisher Copyright: © 2023 by the authors.

PY - 2023/8

Y1 - 2023/8

N2 - In children and adults, chronic cough is a common symptom presenting to health professionals worldwide. It is internationally accepted that children with chronic cough should be managed with pediatric specific management guidelines. The newly proposed clinical entity of ‘cough hypersensitivity syndrome’ has gained significant attention in adult literature. Given the significant differences between childhood and adult chronic cough, including in respiratory physiology and anatomy, and cough sensitivity, we address the suitability of the use of cough hypersensitivity syndrome in children. We explore these differences between childhood and adult chronic cough, explain what cough hypersensitivity is and highlight why the term cough hypersensitivity syndrome should not be used in children.

AB - In children and adults, chronic cough is a common symptom presenting to health professionals worldwide. It is internationally accepted that children with chronic cough should be managed with pediatric specific management guidelines. The newly proposed clinical entity of ‘cough hypersensitivity syndrome’ has gained significant attention in adult literature. Given the significant differences between childhood and adult chronic cough, including in respiratory physiology and anatomy, and cough sensitivity, we address the suitability of the use of cough hypersensitivity syndrome in children. We explore these differences between childhood and adult chronic cough, explain what cough hypersensitivity is and highlight why the term cough hypersensitivity syndrome should not be used in children.

KW - children

KW - cough

KW - evidence

KW - hypersensitivity

KW - review

UR - http://www.scopus.com/inward/record.url?scp=85167677875&partnerID=8YFLogxK

U2 - 10.3390/jcm12154879

DO - 10.3390/jcm12154879

M3 - Article

AN - SCOPUS:85167677875

SN - 2077-0383

VL - 12

SP - 1

EP - 12

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 15

M1 - 4879

ER -

Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this